Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern ...

“Having more of these precursors enables a more sustained supply of active cytotoxic CD8+ T cells for attacking tumors,” said Dr. Mittal, who is also a member of the Sandra and Edward Meyer ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor ...

The treatment with recombinant antibodies and more recently T cell receptor (TCR) engineered T-cell therapies represent two immunological strategies that came into the forefront of clinical interest ...

Furthermore, these cells, called CAR-T cells, appear to be capable of targeting diseased cells in the tumor that do not carry this antigen, while sparing healthy cells. Glioblastoma is the most ...

New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the treatment of ...

The following is a summary of “MATR3 Promotes Liver Cancer Progression by Suppressing DHX58–Mediated Type I Interferon ...